Dividends Calendar Earnings Calendar
ALNY

ALNY | Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Cambridge, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 24.12B
  • Prev closed: 165.11
  • Open: 165.46
  • High: 169.93
  • Low: 162.25
  • 52 week low: 84.97
  • 52 week high: 178.41
  • Dividends:No Dividends

Next ER: November 4, 2021 



Top Stories (ALNY)

    About the Company

    Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 10, 2021
    August 3, 2021-1.61 / -1.6220.55M / 193.06MBeat!
    April 29, 2021-1.71 / -1.75177.57M / 168.5MBeat!
    February 11, 2021-2.09 / -1.78163.56M / 146.64MBeat!
    November 5, 2020-2.18 / -1.63125.85M / 119.05MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Oct 8, 2021 203.70 203.45
    206.84
    202.07
    313.56K 0.39%
    Oct 7, 2021 202.91 201.83
    204.94
    198.85
    307.38K 0.91%
    Oct 6, 2021 201.08 196.04
    201.49
    196.04
    553.01K 1.38%
    Oct 5, 2021 198.35 195.34
    199.69
    195.25
    394.78K 1.71%
    Oct 4, 2021 195.02 195.00
    198.05
    193.01
    606.41K 1.21%
    Oct 1, 2021 192.68 188.42
    193.89
    186.55
    400.32K 2.05%
    Sep 30, 2021 188.81 177.84
    191.41
    177.84
    771.54K 6.40%
    Sep 29, 2021 177.45 178.53
    182.66
    177.00
    388.18K 0.21%
    Sep 28, 2021 177.08 180.27
    184.27
    174.39
    1.25M -8.65%
    Sep 27, 2021 193.85 187.13
    194.47
    181.40
    797.85K 3.44%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:June 2002
    • Employees:1,323 (2019)

    News

    News for (ALNY)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  John Maraganore (Dec 2002–)

    Talk about Alnylam Pharmaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 4, 2021 (Same day)

    amzn gm baba twtr syna sq gpro nok clls trip car w 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 42
    HOLD 58
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInYoutube

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet